AMERIPRISE FINANCIAL INC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 820027
MINNEAPOLIS, MN
Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,470,454
+$706,540 QoQ
Shares Held
95,316
-3.4% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 328 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 64%
None 36%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. HRMY ranks #111 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in HRMY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,470,454 | 95,316 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,763,914 | 98,676 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,286,808 | 221,454 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,594,718 | 94,148 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,926,348 | 92,606 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,346,082 | 100,816 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,571,791 | 103,801 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,402,840 | 85,071 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,656,316 | 88,045 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,195,136 | 95,150 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,199,831 | 99,066 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,617,381 | 110,387 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,825,926 | 108,722 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,597,768 | 110,192 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $9,057,447 | 164,382 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,094,436 | 137,603 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,639,245 | 95,125 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,593,776 | 94,425 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,026,623 | 94,433 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||